Channel Therapeutics Corporation's latest marketcap:
As of 07/03/2025, Channel Therapeutics Corporation's market capitalization has reached $8.23 M. According to our data, Channel Therapeutics Corporation is the 41715th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 8.23 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -7,360,619 |
| Shares Out | 6.6 M |
| EPS (ttm) | -12.4 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/12/2025 |
Channel Therapeutics Corporation's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/03/2025 | $8.23 M | 126.57% | 41715 |
| 12/31/2024 | $3.86 M | n/a |
Company Profile
Channel Therapeutics Corporation, a clinical-stage biotech company, develops and commercializes new therapeutics to alleviate pain.
It targets sodium ion-channel NaV1.7; and develops NaV blockers that target the body’s peripheral nervous system.
The company’s lead compound is CC8464, which has completed Phase 1 clinical trials for the treatment of moderate-to-severe pain in erythromelalgia and idiopathic small fiber neuropathy.
It also develops CT2000 as a topical agent for the treatment of both acute and chronic eye pain; and CT3000 to treat post operative pain with the use of nerve blocks.
The company was Chromocell Therapeutics Corporation and changed its name to Channel Therapeutics Corporation in November 2024.
Channel Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
Frequently Asked Questions
-
What is Channel Therapeutics Corporation's (CHRO) current market cap?As of 07/03/2025, Channel Therapeutics Corporation (including the parent company, if applicable) has an estimated market capitalization of $8.23 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Channel Therapeutics Corporation (CHRO) rank globally by market cap?Channel Therapeutics Corporation global market capitalization ranking is approximately 41715 as of 07/03/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.